Search
for
Sort by
Research 30 of 1000+
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Crosstalk between vimentin and keratins in viral infection: Implications across the viral life cycle
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Store-operated calcium channels in skin
- Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Natural Products as A Promising Therapy for SARS COV-2; An Overview
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?